Back to CVE records
Critical 9.9Published Jun 17, 2026

CVE-2026-46908Vulnerability in the JD Edwards EnterpriseOne Accounts Payable product of Oracle JD Edwards (component: Accounts Payable).

Updated under an hour ago ()

Does this affect you?

It affects oracle jd_edwards_enterpriseone_accounts_payable. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Vulnerability in the JD Edwards EnterpriseOne Accounts Payable product of Oracle JD Edwards (component: Accounts Payable). The supported version that is affected is 9.2. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise JD Edwards EnterpriseOne Accounts Payable. While the vulnerability is in JD Edwards EnterpriseOne Accounts Payable, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of JD Edwards EnterpriseOne Accounts Payable. CVSS 3.1 Base Score 9.9 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H).

CVSS
9.9 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Weakness (CWE)
CWE-284
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Jun 18, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
oracle jd_edwards_enterpriseone_accounts_payable
oracle:jd_edwards_enterpriseone_accounts_payable
9.2
NVD

References

  • vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.